Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
Alaunos Therapeutics
Alaunos Therapeutics
Fate Therapeutics
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Cancer Research UK
Georgetown University